Create a Use Case TWP comprising five (5) distinct use cases. Ensure that you identify what actor(s) are involved. Format in any manner you are comfortable with, but ensure it looks “professional”. (hint: I’m looking for categories of use cases then child use cases)
Create a Use Case TWP comprising five (5) distinct use cases. Ensure that you identify what actor(s) are involved.Format in any manner you are comfortable with, but ensure it looks “professional”. (hint: I’m looking for categories of use cases then child use cases)
2) Create a Non-functional Requirement (NFR) TWP comprising of five (5) distinct requirements. Format in any manner you are comfortable with, but ensure it looks “professional”. (hint: many had “challenges” with NFRs in the assignment... read my input in the forum)
3) (~ 1pg) Discuss how unstructured data and analytics impacts today’s IT projects. What challenges do they introduce for an IT Architect? Can (existing) Analytics help an architect during the design process? (hint: this is a non-trivial exercise given that we didn’t really cover analytics in the course, i.e., this is hard. Understand how big data or social analytics might impact / be used in EA)
4) “Good, Fast, and Cheap... pick any two.“Can proper IT Architecture mitigate or address the triple constraint challenge? (~ 1/2 pg) (no hints... your on your own)
5) Given the adoption and pervasiveness of “agile development” (google this concept) and ever increasing customer expectations in the world of instant cell phone apps, how can you adapt the traditional enterprise architecture approach to be equally agile?
Order This Solution
49051 Millions developed by 10% and working benefit in 2009 was 15012 Millions that developed by 6%. Roche is contributed CHF. 9874 Millions on R&D in 2009. The free trade stream out 2009 was 8893 that was 79% more than 2008. The aggregate representative of Roche are 81507. Out of them 80115 are changeless. The Sales commitment is more from US that is 38% than West Europe that is 28%. Since pharmaceutical advertising exercises impact the endorsing conduct of specialists, it is of most extreme significance to basically dissect the cases made in the limited time material of the medications. The degree to which pharmaceutical organizations advance the benefits of their items and applicable clinical trails give to specialists are not examined in Pakistan. The consequences of the present logical examination demonstrate that untrustworthy and one-sided claims with respect to the pharmaceutical items are uncontrolled in Pakistan. These medication advancements impact the recommending conduct of the General Practitioners, Consultants in this manner representing one of the possibly significant reasons for outlandish solution. Roche Pakistan Ltd is a Member of IFPMA and PMA and take after their moral business rules to offer its items. Roche Paksitan Ltd is at sixth positioning in Pakistan Pharmaceutical Market and its yearly deal is Rs. 5.2 Billions out of 2009 in Pakistan.>GET ANSWER